Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Dose-Response Study in Total Knee Replacement
NCT00097357Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), pulmonary embolism (PE), sponsored by Bristol Myers Squibb. Started Oct 2004; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00097357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097357.